SCHEMBL6732336

SCHEMBL6732336

Oc1c(I)cc(-c2cn(Cc3ccccc3)nn2)cc1I

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.66
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
HSP90AA1 P07900 2/20 0.56
HSP90AB1 P08238 2/20 0.56
ROCK2 O75116 4/20 0.56
CDK2 P24941 4/20 0.56
GSK3B P49841 4/20 0.56
CDC7 O00311 4/20 0.56
PIM1 P11309 3/20 0.56
PRKACA P17612 3/20 0.56
MAP4K4 O95819 2/20 0.56
HIPK2 Q9H2X6 2/20 0.56
IRAK4 Q9NWZ3 2/20 0.56
CLK4 Q9HAZ1 1/20 0.56
MKNK2 Q9HBH9 1/20 0.56
FLT3 P36888 1/20 0.55
HDAC8 Q9BY41 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
HDAC3 O15379 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL935182 0.80 CYP19A1 (1.00) CYP19A1NPC1RAB9AROCK2CDK2
SCHEMBL15836586 0.80 CYP19A1 (0.93) CYP19A1NPC1RAB9AROCK2CDK2
SCHEMBL12022166 0.79 CYP19A1 (0.84) CYP19A1NPC1RAB9AROCK2CDK2
SCHEMBL28814340 0.79 ESRRG (0.70) CYP19A1NPC1RAB9AHSP90AA1HSP90AB1
SCHEMBL12037700 0.79 CYP19A1 (0.68) CYP19A1NPC1RAB9AHSP90AA1HSP90AB1
Acetic Acid SCHEMBL28328686 0.78 CYP19A1 (0.82) CYP19A1NPC1RAB9AGSK3BFLT3
SCHEMBL22510634 0.78 CYP19A1 (0.82) CYP19A1NPC1RAB9AROCK2CDK2
SCHEMBL12535881 0.77 NPC1 (0.88) CYP19A1NPC1RAB9AGSK3BFLT3
SCHEMBL16050564 0.76 CYP19A1 (0.72) CYP19A1NPC1RAB9AROCK2CDK2
SCHEMBL29352717 0.76 CYP19A1 (0.72) CYP19A1NPC1RAB9AROCK2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6677473-B1 TREATMENT, PREVENTION OR AMELIORATION OF ONE OR MORE SYMPTOMS OF THROMBOTIC DISORDERS, UNSTABLE ANGINA OR CANCER CORVAS INTERNATIONAL INC 2004-01-13 US disclosed
WO-2001036351-A2 PLASMINOGEN ACTIVATOR INHIBITOR ANTAGONISTS RELATED APPLICATIONS CORVAS INTERNATIONAL, INC. (US) 2001-05-25 WO disclosed